OptiBiotix Health (GB:OPTI) has released an update.
OptiBiotix Health PLC faces a setback as Peterhouse Capital Limited denies their request to vote on the removal of ProBiotix’s CEO, citing concerns over the company’s leadership stability. This decision comes amid a sharp decline in ProBiotix’s share price and market cap since the CEO change in January 2023, raising investor concerns about management’s alignment with shareholder interests. OptiBiotix urges shareholders to vote for resolutions that could prevent further erosion of shareholder value.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
